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Objective. To assess prospectively the feasibility and durability of subintimal angioplasty (SA) clinically and by duplex
scans every 3 months.
Patients and methods.Within a period of 54 months, we selected 96 patients with 100 occlusions (mean length: 11.5 cm)
of femoro-popliteal or tibial arteries, for SA.
Results. The technical success rate was 88% and seven out of 12 failures were treated by conventional surgery. Five below-
the-knee amputations were performed despite a patent recanalization. The following complications occurred: arterial
perforation (6), arterial thrombosis (4), extensions beyond the planned re-entry site (5), and arterial dissection (2). Primary,
assisted-primary and secondary patency rates were 61, 68 and 74%, respectively at 24 months. The 24 month-limb salvage
and survival rates were 78 and 85%, respectively. Duplex imaging demonstrated 10 restenosis (five symptomatic . 70%,
five asymptomatic 30–70%), seven occlusions (five asymptomatic, two symptomatic treated by a bypass) and one
asymptomatic dilatation.
Conclusion. In a selected group of patients SA is feasible with a high initial technical success rate. SA is a good alternative
in patients who are poor candidates for bypass surgery.
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Introduction
Intraluminal angioplasty is currently considered as the
treatment of choice of short femoro-popliteal stenosis.1
However, for long femoro-popliteal occlusions treated
by this technique, the patency rates are poor2 and
bypass surgery remains the procedure of choice.1 The
development of subintimal angioplasty (SA) allows
long femoro-popliteal occlusions3 and infra-popliteal
artery disease4 to be treated. In a group of 200
consecutive patients with long femoro-popliteal occlu-
sions treated by SA, a 12 months clinical patency rate
of 71% was reported.5 Other institutions have shown
comparable initial success rates, with a primary and
secondary patency of 59 and 65%, respectively at 2
years.6 During follow-up, clinical presentation and
ankle–brachial indices were the only studies routinely
performed and, therefore, the anatomical success of
the technique was not reported. We have prospectively
analysed the outcome of consecutive patients treated
by SA clinically and by duplex every 3 months in order
to assess the feasibility and further evaluate the long-
term durability of this technique.
Patients and Methods
From November 1, 1998, to April 10, 2003, we selected
96 patients with 100 occlusions of femoro-popliteal or
tibial arteries, for SA (mean age: 72 years; range 44–
90). This subset represents 12.7% of 785 total infra-
inguinal revascularizations performed over the 5-year
period in our unit. The demographic data of the
patients are shown in Table 1. All patients were
followed at 3-month intervals by means of clinical and
duplex ultrasound examination. Arteries identified
with duplex abnormalities were evaluated with
angiography. A PTA was proposed if the arteriogram
confirmed the area of restenosis. A bypass was
proposed in cases of occlusion.
Technique
All patients underwent a diagnostic angiogram. The
following factors were used to select patients for SA:
Eur J Vasc Endovasc Surg 28, 138–141 (2004)
doi: 10.1016/j.ejvs.2004.02.020, available online at http://www.sciencedirect.com on
*Corresponding author. Pascal Desgranges, Department of Vascular
Surgery, Henri Mondor Hospital, 51, Avenue du Marechal de Lattre
de Tassigny, 94010 Creteil, France.
1078–5884/020138 + 04 $35.00/0 q 2004 Elsevier Ltd. All rights reserved.
lack of vein available for bypass, severe medical
co-morbidities, long standing femoro-popliteal or
tibial occlusion with a good starting stump and the
presence of at least one correct distal run-off vessel. We
used the technique of Bolia with slight modification.
The ipsilateral common femoral artery was punctured
anterogradely and followed by the insertion of a 6
French introducer (Terumo, Tokyo, Japan). Systemic
heparin (50 units/kg) was then given. In case of an
occlusion shorter than 5 cm, a transluminal recanaliza-
tion was attempted first with the help of a hydrophilic
guidewire (180 cm long, 0.035 in. diameter and angled,
Terumo). For occlusions longer than 5 cm or where
transluminal angioplasty had failed, SA was
attempted. Then a 5F Van Andel predilating catheter
(Cook, Charenton, France) was introduced up to the
start of the occlusion. Then the occlusion was crossed
using the combination of a Terumo wire making a loop
and a Van Andel Catheter until the point of re-entry
within the true arterial lumen. At the beginning of our
experience (first 46 patients), once the lesion was
crossed, a 5F balloon catheter of 3–6 mm diameter and
2–4 cm long was inflated throughout the entire length
of the subintimal channel using 10–12 pressure
atmospheres at 10-second inflations. Now, we perform
brief inflations at low pressure. For vessels of less than
4-mm diameter, the Terumo wire was exchanged for a
0.014 wire (Spartacore, Guidant, Rueil Malmaison,
France) and a monorail balloon (Herculink, Guidant,
France) was mounted. Technical success was defined
as a recanalization with 30% or less residual stenosis
and antegrade flow on completion angiogram. After
successful recanalization, all patients received aspirin
at 250 mg/day and clopidogrel (plavix) for 1 month,
followed by aspirin alone.
Results
Immediate results
Technical success was achieved in 88 out of 100 cases
(88%). The technical failures were due to inability to
enter the subintimal space ðn ¼ 2Þ; failure to progress
the wire in a calcified vessel ðn ¼ 3Þ and failure to re-
enter the distal lumen ðn ¼ 7Þ: Five (intermittent
claudication three, critical limb ischaemia two) out of
12 failures were not surgically treated because the limb
was clinically improved. Seven failures needed a
bypass. In three cases, we had to perform longer
bypasses than scheduled from above knee to below
knee because of the extension of the dissection lower
than the end of the occlusion in order to achieve re-
entry.
Immediate clinical success (defined as the freedom
of claudication among the claudicants or the improve-
ment of patients in CLI i.e. the absence of amputation)
was achieved in 80/100 cases. In five cases, we
performed a below knee amputations despite techni-
cal success.
Seventeen immediate complications were observed
(17%): non-severe perforations (requiring neither
blood transfusion nor reoperation) ðn ¼ 6Þ; extension
of the dissection beyond the planned re-entry site
superior to 5 cm ðn ¼ 4Þ (Fig. 1), thrombosis treated by
thrombolysis ðn ¼ 5Þ; threatening dissection treated by
a stent ðn ¼ 2Þ:
Long-term results
The mean follow-up time was 14.5 months and 14
patients were lost to follow-up (15%). Primary,
assisted-primary and secondary patency rates were
61, 69 and 74%, respectively at 24 months (Fig. 2). The
24 month-limb salvage rate was 78% and survival rate
was 85%. Eighteen morphologic abnormalities (18%)
were observed by duplex: 10 restenoses (five
symptomatic . 70%, that were treated by a new PTA
(Fig. 3), five asymptomatic 30–70% that were not
redilated), seven occlusions (five asymptomatic, two
symptomatic treated by distal bypass) and one
asymptomatic dilatation.
Discussion
Similar to other investigators, we have shown SA to be
feasbile for long occlusions.7,8 We have confirmed that
SA is simple in the presence of a good starting stump,
the absence of a heavily calcified occlusion and at least
Table 1.
Demographic data n %
Claudication 46 48
Critical limb ischemia 50 52
Smocking 62 64
Diabetes 63 66
Hypertension 69 72
Coronary artery disease 38 40
Site of occlusions
Femoro-popliteal 82 82
Tibial 18 18
Length of occlusion
. 10 cm 31 31
5–10 cm 63 63
, 5 cm 6 6
Mean (cm) 11.5 (4–40)
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one patent distal run-off vessel. SA offers many
advantages compared to conventional bypass surgery.
SA is minimally invasive and a fast treatment that can
be performed under local anaesthesia in connection
with routine diagnostic angiography. In addition, SA
provides much less wound complications than
observed after removal of the great saphenous vein.
With few exceptions (McCarthy et al.,7), other
investigators have found SA to be durable. However,
none of the reported series have carried out complete
surveillance to evaluate the long-term patency of the
procedures. Instead the investigators have choosen to
report symptomatic or hemodynamic patency. How-
ever, the absence of clinical events is not equivalent to
anatomical patency of the SA. In our studies, we have
shown that the primary patency rates checked by US-
Doppler were 61% at 24 months. These results are
respectable and far better than achieved with trans-
luminal angioplasty, although not as good as saphe-
nous bypass. We can conclude that patency rates
reached by SA for treatment of long femoro-popliteal
lesions (TASC D) are intermediary between those
obtained with saphenous bypass (66 and 80% at 5
years for critical limb ischaemia and claudication,
respectively2) and transluminal angioplasty
(occlusions . 3 cm: 37% at 2 years;9 occlusions .
5 cm, 4% at 6 months,10 occlusions of mean length of
16.5 cm: 22% at 1 year.11).
However, the durability of SA may be affected by a
17% incidence at 2 years of reocclusions and rest-
enosis. Fortunately, most of these abnormalities do not
lead to symptoms and only five secondary PTA and
two bypasses were performed. Thus, these abnormal-
ities do not reflect the clinical status and may explain
the good ‘clinical patency’ reported by Bolia et al. Even
if a PTA site does re-stenose or re-occlude, the limb
may remain asymptomatic and viable probably due to
the development of collaterals.
Fig. 1. Left: occlusion of the distal superficial femoral artery. The planned re-entry site is located at the hunter’s canal. Right:
successful recanalization but extension of the dissection beyond planned re-entry site and final re-entry site located at the
level of the infra-popliteal artery.
                                                    
Fig. 2. Primary patency curve by life table method.
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Because of the initial high technical success and the
respectable mid-term durability, should we advocate
SA as a first-line therapy in all the femoro-popliteal/-
tibial occlusions? At the beginning of our experience,
we reserved this technique to selected patients: after
unsuccessful transluminal angioplasty of lesions
inferior to 5 cm; patients with longer lesions in the
absence of vein and/or with severe comorbidities or
short life expectancy. In this group of patient, although
surgery may provide a better anatomic patency, this
may not translate into clinical outcome because many
patients may not live long enough to reap the benefits.
At the present time, we have expanded the selection of
the patient giving more attention to the anatomical
factors, such as the avoidance of a heavily calcified
vessel, the presence of a good starting stump and a
correct distal landing vessel.
Another question remains: does a failed SA jeopar-
dize subsequent surgical reconstruction? Although,
we did not loose any limbs due to a complication of the
technique itself, in four cases the re-entry site was far
lower than scheduled, with the requirement in three to
perform a below knee rather than an above knee
bypass.
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Fig. 3. (A) 6 cm popliteal occlusion; (B) completion angiogram after subintimal angioplasty; (C) restenosis that was further re-
dilated. Subintimal angioplasty: doable and rather durable.
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